Flavonoids Identified in Terminalia spp. Inhibit Gastrointestinal Pathogens and Potentiate Conventional Antibiotics via Efflux Pump Inhibition
Open Access
Abstract
The genus Terminalia has a long history of use in traditional medicine to treat various diseases, including bacterial infections. We previously reported a metabolomic analysis using liquid chromatography–mass spectrometry of selected Australian Terminalia spp. and highlighted numerous flavonoids that may contribute to the antimicrobial activities of those plants. This study examines the antibacterial activities of fifteen flavonoids found in Terminalia spp. against a range of gastrointestinal pathogens using broth dilution assays. Flavonoids were also combined with six different classes of conventional antibiotics to investigate interactions. The efflux pump inhibitory activity of the flavonoid was evaluated using ethidium bromide accumulation and efflux assays. Toxicities were assessed via human dermal fibroblast cell line assays. Fisetin, hispidulin, isoorientin, orientin, rutin, and vitexin showed noteworthy growth inhibitory activity (MIC values 62.5–250 µg/mL). Isoorientin and orientin were most potent against Bacillus cereus and Alcaligenes faecalis, displaying MIC values of 62.5 µg/mL against both bacteria. All flavonoids except genistein, isorhamnetin, kaempferol, luteolin, taxifolin, and vitexin were nontoxic in human dermal fibroblast (HDF) cell proliferation assays. When individual flavonoids were combined with selected antibiotics, some potentiated the activity of these antibiotics. Two synergistic, eighteen additive and thirty-one non-interactive interactions were observed. The synergistic interactions were all observed in combination with orientin. Notably, orientin exhibited efflux pump inhibitory effects at concentrations from 15.26 µg/mL to 125 µg/mL. The findings reported herein indicate that the selected flavonoids have the potential for addressing bacterial antibiotic resistance and highlight the need for further study.Keywords
This publication has 35 references indexed in Scilit:
- Antimicrobial activity of selected native Australian Terminalia spp. against gastrointestinal pathogens and potentiation of selected antibioticsPharmacological Research - Natural Products, 2025
- Antimicrobial activities of lavandulylated flavonoids in Sophora flavences against methicillin-resistant Staphylococcus aureus via membrane disruptionJournal of Advanced Research, 2023
- Use of specific combinations of the triphala plant component extracts to potentiate the inhibition of gastrointestinal bacterial growthJournal of Ethnopharmacology, 2020
- Effect of flavonoids on antimicrobial activity of microorganisms present in dental plaqueHeliyon, 2019
- Comprehensive review of antimicrobial activities of plant flavonoidsPhytochemistry Reviews, 2018
- Understanding the mechanisms and drivers of antimicrobial resistanceThe Lancet, 2016
- The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae)Inflammopharmacology, 2015
- The DNA intercalators ethidium bromide and propidium iodide also bind to core histonesFEBS Open Bio, 2014
- Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide methodInternational Journal of Antimicrobial Agents, 2008
- Characterization of quercetin binding site on DNA gyraseBiochemical and Biophysical Research Communications, 2003